Discovery and Preclinical

BGI Pharma Solutions

Building on a full portfolio of NGS and proteomics services, BGI offers end-to-end genomics solutions for drug R&D, including target discovery pre-clinical development, biomarker development and clinical trial testing. In addition, we can support and execute molecular diagnostic development, IVD registration and commercialization for the pharmaceutical industry in the Chinese market.